Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Africa In The News.
Press releases published on September 29, 2025
AskNetwork247 Launches to Help Africans Across the Globe to Source Jobs, Customers, and Business Partners
Introduce me to the right person! Simplified. BIRMINGHAM, BIRMINGHAM, UNITED KINGDOM, September 29, 2025 /EINPresswire.com/ -- A new digital platform, AskNetwork247, has been launched to help Africans at home and abroad navigate one of the most pressing …
2025 iGaming Report: Fraud on the Rise in Ghana’s Betting Sector Despite Africa’s Progress
ACCRA, GHANA, September 29, 2025 /EINPresswire.com/ -- Ghana’s iGaming industry is confronting mounting challenges in fraud prevention, even as Africa overall makes progress in reducing fraud across the sector. Recent findings by Sumsub, a full-cycle …
Turkish Furniture Exports Gain Momentum in Africa, Asortie Among Leading Contributors
Turkey strengthens its position in Africa’s growing furniture market, with Asortie delivering projects in over 15 countries across the continent. ISTANBUL, ISTANBUL, TURKEY, September 29, 2025 /EINPresswire.com/ -- Furniture exports from Turkey to …
Prime Mining Securityholders Approve Transaction with Torex Gold
VANCOUVER, British Columbia, Sept. 29, 2025 (GLOBE NEWSWIRE) -- Prime Mining Corp. (“Prime” or the “Company”) (TSX: PRYM) (OTCQX: PRMNF) (Frankfurt: O4V3) announces that the Company's securityholders have approved the plan of arrangement (the "Arrangement …
Helium Evolution Secures Offtake Agreement
CALGARY, Alberta, Sept. 29, 2025 (GLOBE NEWSWIRE) -- Helium Evolution Incorporated (TSXV:HEVI) ("HEVI" or the "Company"), a Canadian-based helium exploration company focused on developing assets in southern Saskatchewan, is pleased to announce the signing …
Lesaka’s Final FY2025 Results: Delivers on FY2025 Profitability Guidance, Reaffirms FY2026 Profitability & Net Revenue Outlook, and Sets FY2026 Profitability per Share Guidance, reflecting more than 100% Year-on-Year Growth
JOHANNESBURG, Sept. 29, 2025 (GLOBE NEWSWIRE) -- Lesaka Technologies, Inc. (Nasdaq: LSAK; JSE: LSK) today released results for the fourth quarter (“Q4 2025”) and full year of fiscal 2025 (“FY2025”). FY2025 performance: All growth rates are year-on-year …
Cogent Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
WALTHAM, Mass. and BOULDER, Colo., Sept. 29, 2025 (GLOBE NEWSWIRE) -- Cogent Biosciences, Inc. (Nasdaq: COGT), a biotechnology company focused on developing precision therapies for genetically defined diseases, today announced that on September 25, 2025, …
Septerna Appoints Veteran Biotechnology Leader Keith Gottesdiener, M.D., to its Board of Directors
SOUTH SAN FRANCISCO, Calif., Sept. 29, 2025 (GLOBE NEWSWIRE) -- Septerna, Inc. (NASDAQ: SEPN), a clinical-stage biotechnology company pioneering a new era of G protein-coupled receptor (GPCR) drug discovery, today announced the appointment of Keith …
Critical Metals Corp Amends Agreement to Acquire a Controlling Interest in Tanbreez
NEW YORK, Sept. 29, 2025 (GLOBE NEWSWIRE) -- Critical Metals Corp. (Nasdaq: CRML) (“Critical Metals Corp” or the “Company”), a leading critical minerals mining company, today announced that it has amended its agreement to acquire the Tanbreez Greenland …
Silo Pharma Updates Strategic Agreement with Fireblocks to Secure Crypto Treasury Management
Fireblocks is a globally recognized leader in the digital assets space, facilitating the secure transfer of more than $10 trillion to date SARASOTA, FL, Sept. 29, 2025 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (Nasdaq: SILO) (“Silo” or “the Company), a …
NexGold Announces Closing of US$24 Million Royalty
TORONTO, Sept. 29, 2025 (GLOBE NEWSWIRE) -- NexGold Mining Corp. (TSXV: NEXG; OTCQX: NXGCF) (“NexGold” or the “Company”) is pleased to announce that it has closed its previously announced financing for a 2.9% net smelter returns royalty (the “Royalty”) …
XS.com Assume a Liderança como Patrocinador Diamante da Credi Expo 2025 no México
BRAZIL, September 29, 2025 /Business News/ -- XS.com, a corretora globalmente reconhecida de múltiplos ativos e líder em fintech, tem a honra de anunciar sua participação como Patrocinador Diamante da Credi Expo 2025, que acontecerá em 2 e 3 de outubro …
Forsys Announces Upsize of Bought Deal LIFE Private Placement for Gross Proceeds of C$17.0 Million
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR RELEASE, PUBLICATION, DISTRIBUTION OR DISSEMINATION DIRECTLY, OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES. TORONTO, Sept. 29, 2025 (GLOBE NEWSWIRE) -- Forsys Metals Corp. ( …
Spectral Medical Inc. Files Base Shelf Prospectus and Revised AIF
TORONTO, Sept. 29, 2025 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), a late-stage theranostic company advancing therapeutic options for sepsis and septic shock, announced that it has filed a final short form base …
Revolution Medicines Announces Key Leadership Additions, including Alan Sandler, M.D. as Chief Development Officer
REDWOOD CITY, Calif., Sept. 29, 2025 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a late-stage clinical oncology company developing targeted therapies for patients with RAS-addicted cancers, today announced the appointment of Alan Sandler …
Cue Biopharma Announces Strategic Transition in Leadership to Further Enable Next Stage of Growth with Disruptive Autoimmune Therapeutic Candidates
Usman Azam, M.D., is appointed President and Chief Executive Officer of Cue Biopharma, effective September 29, 2025 Daniel Passeri, Chief Executive Officer of Cue Biopharma, transitions to Strategic Advisor to provide ongoing support to the Company Cue …
Outlook Therapeutics Provides Update on Type A Meeting with FDA
ISELIN, N.J., Sept. 29, 2025 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company focused on optimizing the standard of care for bevacizumab for the treatment of retina diseases, today announced that it has completed …
CorMedix Announces Completion of Enrollment in Phase III ReSPECT Clinical Trial for REZZAYO
- Enrollment Completed in Ongoing Phase III ReSPECT Study in Prophylaxis of Fungal Infections in Adult Patients Undergoing Allogeneic Blood and Marrow Transplant - - Topline Results from ReSPECT Study Expected in 2Q 2026 - BERKELEY HEIGHTS, N.J., Sept. 29, …